Search research articles
Contact Us
Filters
Showing results (51-60 of 493) with videos related to
Page
of 50
Sort By:
Cancer Management and Research
|
December 29, 2010
Management of metastatic renal cell carcinoma in patients with poor prognosis
Andrea Bullock, David F McDermott, Michael B Atkins
Journal for Immunotherapy of Cancer
|
March 10, 2023
Navigating and adapting care integrating immunotherapy, antiangiogenic therapy, and combinations in patients with advanced renal cell carcinoma
Brian I Rini, James Brugarolas, Michael B Atkins
Expert Opinion on Biological Therapy
|
December 19, 2003
18th Annual Scientific Meeting of the International Society for Biological Therapy of Cancer. 30 October-2 November 2003, Bethesda, Maryland, USA
Francesco M Marincola, Ena Wang, Michael B Atkins
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 27, 2007
Opportunities and obstacles to combination targeted therapy in renal cell cancer
Jeffrey A Sosman, Igor Puzanov, Michael B Atkins
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 13, 2006
Targeting the mitogen-activated protein kinase pathway in the treatment of malignant melanoma
David J Panka, Michael B Atkins, James W Mier
The Oncologist
|
March 1, 2018
Second-Line Treatment Landscape for Renal Cell Carcinoma: A Comprehensive Review
Nizar M Tannir, Sumanta K Pal, Michael B Atkins
Physics in Medicine and Biology
|
November 1, 1980
The geometric transfer function component for scintillation camera collimators with straight parallel holes
C E Metz, F B Atkins, R N Beck
Journal of Translational Medicine
|
July 5, 2015
What's new in melanoma? Combination!
Paolo A Ascierto, Francesco M Marincola, Michael B Atkins
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 1, 1996
Positive technetium-99m-red blood cell gastrointestinal bleeding scan after barium small-bowel study
P K Rehm, F B Atkins, H A Ziessman
Cancers
|
February 15, 2022
Combination of Anti-Angiogenics and Checkpoint Inhibitors for Renal Cell Carcinoma: Is the Whole Greater Than the Sum of Its Parts?
Eric Jonasch, Michael B Atkins, Simon Chowdhury, et al.
Page
of 50
Search research articles
Search
Showing results (51-60 of 493) with videos related to
Sort By:
Page
of 50
Cancer Management and Research
|
December 29, 2010
Management of metastatic renal cell carcinoma in patients with poor prognosis
Andrea Bullock, David F McDermott, Michael B Atkins
Journal for Immunotherapy of Cancer
|
March 10, 2023
Navigating and adapting care integrating immunotherapy, antiangiogenic therapy, and combinations in patients with advanced renal cell carcinoma
Brian I Rini, James Brugarolas, Michael B Atkins
Expert Opinion on Biological Therapy
|
December 19, 2003
18th Annual Scientific Meeting of the International Society for Biological Therapy of Cancer. 30 October-2 November 2003, Bethesda, Maryland, USA
Francesco M Marincola, Ena Wang, Michael B Atkins
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 27, 2007
Opportunities and obstacles to combination targeted therapy in renal cell cancer
Jeffrey A Sosman, Igor Puzanov, Michael B Atkins
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 13, 2006
Targeting the mitogen-activated protein kinase pathway in the treatment of malignant melanoma
David J Panka, Michael B Atkins, James W Mier
The Oncologist
|
March 1, 2018
Second-Line Treatment Landscape for Renal Cell Carcinoma: A Comprehensive Review
Nizar M Tannir, Sumanta K Pal, Michael B Atkins
Physics in Medicine and Biology
|
November 1, 1980
The geometric transfer function component for scintillation camera collimators with straight parallel holes
C E Metz, F B Atkins, R N Beck
Journal of Translational Medicine
|
July 5, 2015
What's new in melanoma? Combination!
Paolo A Ascierto, Francesco M Marincola, Michael B Atkins
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 1, 1996
Positive technetium-99m-red blood cell gastrointestinal bleeding scan after barium small-bowel study
P K Rehm, F B Atkins, H A Ziessman
Cancers
|
February 15, 2022
Combination of Anti-Angiogenics and Checkpoint Inhibitors for Renal Cell Carcinoma: Is the Whole Greater Than the Sum of Its Parts?
Eric Jonasch, Michael B Atkins, Simon Chowdhury, et al.
Page
of 50